We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$701K
Cap. Flow
-$16.4M
Cap. Flow %
-8.91%
Top 10 Hldgs %
51.23%
Holding
107
New
12
Increased
18
Reduced
32
Closed
25

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.89M
2
BABA icon
Alibaba
BABA
+$1.31M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.09M
4
LFCR icon
Lifecore Biomedical
LFCR
+$965K
5
YETI icon
Yeti Holdings
YETI
+$443K

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$2.33M
2
ABBV icon
AbbVie
ABBV
+$1.75M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.28M
4
T icon
AT&T
T
+$1M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$986K

Sector Composition

Rank Sector Weight
1 Healthcare 32.01%
2 Technology 17.2%
3 Communication Services 6.8%
4 Consumer Discretionary 4.09%
5 Financials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
76
CALL
Incyte
INCY
$24.2B
$62.8K 0.03%
+1,000
New +$56.6K
OVID icon
77
Ovid Therapeutics
OVID
$414M
$60.3K 0.03%
18,730
-11,700
-38% -$40K
UNG icon
78
United States Natural Gas Fund
UNG
$456M
$58.3K 0.03%
2,875
-875
-23% -$21.8K
ARQ icon
79
Arq
ARQ
$84.6M
$40.2K 0.02%
+13,496
New +$30.1K
ARQ icon
80
CALL
Arq
ARQ
$84.6M
$11.9K 0.01%
+4,000
New +$8.93K
AMRN
81
Amarin Corp
AMRN
$298M
$11.6K 0.01%
665
-40
-6% -$628
AAPL icon
82
PUT
Apple
AAPL
$4.54T
– –
-3,500
Closed -$599K
AIRT icon
83
Air T
AIRT
$75.5M
– –
-9,135
Closed -$204K
AMD icon
84
CALL
Advanced Micro Devices
AMD
$776B
– –
-3,000
Closed -$308K
AMGN icon
85
PUT
Amgen
AMGN
$208B
– –
-3,000
Closed -$806K
AMZN icon
86
Amazon
AMZN
$2.92T
– –
-5,000
Closed -$636K
BMY icon
87
CALL
Bristol-Myers Squibb
BMY
$133B
– –
-42,600
Closed -$2.47M
BMY icon
88
Bristol-Myers Squibb
BMY
$133B
– –
-5,250
Closed -$305K
BMY icon
89
PUT
Bristol-Myers Squibb
BMY
$133B
– –
-4,000
Closed -$232K
EQ icon
90
Equillium
EQ
$139M
– –
-69,871
Closed -$51.7K
GLD icon
91
PUT
SPDR Gold Trust
GLD
$131B
– –
-10,500
Closed -$1.8M
INTC icon
92
CALL
Intel
INTC
$455B
– –
-7,500
Closed -$267K
MSFT icon
93
PUT
Microsoft
MSFT
$3.45T
– –
-1,000
Closed -$316K
MU icon
94
CALL
Micron Technology
MU
$930B
– –
-9,000
Closed -$612K
MU icon
95
PUT
Micron Technology
MU
$930B
– –
-1,000
Closed -$68K
ORCL icon
96
PUT
Oracle
ORCL
$374B
– –
-10,000
Closed -$1.06M
PARA
97
DELISTED
Paramount Global Class B
PARA
– –
-12,500
Closed -$161K
QCOM icon
98
PUT
Qualcomm
QCOM
$155B
– –
-5,000
Closed -$555K
REGN icon
99
PUT
Regeneron Pharmaceuticals
REGN
$78.5B
– –
-1,400
Closed -$1.15M
RTX icon
100
CALL
RTX Corp
RTX
$290B
– –
-10,000
Closed -$720K
1 2 3
4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, DCF Advisers held 107 positions worth $184M, up 0.38% from $184M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers withdrew a net $16.4M in Q4 2023, closing 25 positions and reducing 32 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Yeti Holdings worth $518K.

  • DCF Advisers's largest Q4 2023 buy was Yeti Holdings: 10,000 shares worth $518K.
  • DCF Advisers added most to Revance Therapeutics, Inc. in Q4 2023, an estimated $1.89M increase.
  • DCF Advisers's biggest Q4 2023 reduction was AbbVie, cutting an estimated $1.75M.
  • DCF Advisers fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $2.33M.
  • DCF Advisers's ten largest holdings make up 51% of its $184M portfolio in Q4 2023.
  • DCF Advisers opened 12 new positions and closed 25 in Q4 2023.
  • DCF Advisers's portfolio value rose 0.38% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.